ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

HEMO Hemogenyx Pharmaceuticals Plc

1.352
-0.083 (-5.78%)
Last Updated: 08:30:09
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Hemogenyx Pharmaceuticals Plc LSE:HEMO London Ordinary Share GB00BYX3WZ24 ORD GBP0.01
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.083 -5.78% 1.352 1.352 1.598 1.352 1.352 1.35 64,639 08:30:09
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Finance Services 0 -6.69M -0.0050 -2.86 19.26M
Hemogenyx Pharmaceuticals Plc is listed in the Finance Services sector of the London Stock Exchange with ticker HEMO. The last closing price for Hemogenyx Pharmaceuticals was 1.44p. Over the last year, Hemogenyx Pharmaceuticals shares have traded in a share price range of 1.002p to 6.30p.

Hemogenyx Pharmaceuticals currently has 1,341,815,988 shares in issue. The market capitalisation of Hemogenyx Pharmaceuticals is £19.26 million. Hemogenyx Pharmaceuticals has a price to earnings ratio (PE ratio) of -2.86.

Hemogenyx Pharmaceuticals Share Discussion Threads

Showing 13376 to 13394 of 13625 messages
Chat Pages: 545  544  543  542  541  540  539  538  537  536  535  534  Older
DateSubjectAuthorDiscuss
25/4/2024
06:42
How are your 2.3p PPP shares doing purple11?....... LOL

Simples!........ :-)

nigoil
25/4/2024
06:27
Lots of admin expenses
countbasie1
25/4/2024
06:12
Unfortunately this is screwed as an investment. They have pal but admitted more funding will be required over and over again.. Death spiral finance will wipe out shareholders value here. Possible end up going private once they have milked what they can out of shareholders. Sad state of affairs for most small cap companies now. Don't life in hope relaity is death spiral
bones698
24/4/2024
09:04
like a lion sitting by the oasis waiting for a mug punter

working capitol feeling parched.

dreamtwister
23/4/2024
08:08
looking for a move to 2.5-4p

an explosive move on good news

the science continues..

purple11
23/4/2024
07:29
How's your 2.3p PPP shares doing purple11?.....LOL

Simples!.......;-)

nigoil
23/4/2024
07:01
122856 my BUY@1.615

Will add twice more higher or lower gl

purple11
22/4/2024
21:47
hemo often pushes the price up to 4p on good news

i expect another go

2 1/2p a nice trade for a thousand

buying at 1.5p always pays off in hemo

purple11
22/4/2024
21:29
yes i will ofcourse
purple11
22/4/2024
21:23
Being so candid, Purple, I assume you'll be posting your 'Buy' on here when you do tomorrow. When you don't, please expect nothing less than what you deserve...
bahamarama
22/4/2024
20:49
this is the kinda price i was hoping to buy at so i will in the morning.

good luck everyone.

purple11
12/4/2024
10:39
By tempted back in below 1.4
trying2trade
12/4/2024
08:59
biodefence still rumbling.



This issue may be on going so this gives Dr Sandler the opportunity to implement

a alternative supplier ?

dreamtwister
10/4/2024
13:28
Doing well innit
albert35911
09/4/2024
14:19
interesting link below, custom & off the shelf car-t manufacturing pro`s & cons ?

hemogenyx have chosen to go down the custom route,

dreamtwister
08/4/2024
19:54
FDA accepts Shorla’s oral liquid leukemia drug NDA

SH-201 is an oral liquid drug, making the treatment accessible to patients who may struggle with taking tablets or other dosage forms. It slows or stops the growth of certain forms of leukemia, including chronic myeloid leukemia and acute lymphoblastic leukemia.

The blood science is becoming more accessible & cost effective....㇮6;

Below the link gives a insight to the Car-t science.

dreamtwister
08/4/2024
08:05
well the cd38 therapy has been approved, Dr Sandler has now to bring cd19 to the clinical trials.
dreamtwister
07/4/2024
18:54
hxxps://www.biospace.com/article/biotech-bankruptcies-skyrocket/

Hemo next? bankruptcies skyrocket in biotech !! WHO OWNS HEMO CASINO SHARES !!?

marcus80
07/4/2024
17:12
Great news ! FDA allows expanded use of cell therapies for blood cancer
The drugs from Johnson & Johnson and Bristol Myers Squibb can be used to treat patients in the earlier stages of a type of blood cancer.

dreamtwister
Chat Pages: 545  544  543  542  541  540  539  538  537  536  535  534  Older

Your Recent History

Delayed Upgrade Clock